Live Breaking News & Updates on Sunovion Pharms Inc

Stay updated with breaking news from Sunovion pharms inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

"About" Patent Claim Construction: Par v. Hospira | Harris Beach PLLC


To embed, copy and paste the code into your website or blog:
The use of the word “about” in a patent claim as part of a numeric range might permit the patent holder to preclude competitor formulations falling outside the approximate range, as illustrated in a fairly recent decision
Par Pharm., Inc. v. Hospira, Inc., 835 F. App x 578 (Fed. Cir. 2020). Par sued Hospira for patent infringement after Hospira filed an ANDA seeking to market a generic version of Par’s Adrenalin
® epinephrine injection. At issue was the scope of the patent claim listing the
approximate amounts of tonicity, chelating, and pH lowering agents added to the epinephrine formulation for stability. ....

United States , Teva Pharms , United States Inc , Hospira Inc , Sunovion Pharms Inc , Spharm Inc , Par Pharm , Federal Circuit , Sunovion Pharms , ஒன்றுபட்டது மாநிலங்களில் , தேவா ஃபார்ம்ஸ் , ஒன்றுபட்டது மாநிலங்களில் இன்க் , பார்ம் இன்க் , இணையானது பார்ம் , கூட்டாட்சியின் சுற்று ,